Intraoperative IABP and levosimendan use in cardiас surgery

V. V. Lomivorotov; V. A. Boboshko; A. V. Boboshko; A. M. Cherniavskiy; D. A. Nikolaev; I. A. Kornilov; A. N. Shilova; V. N. Lomivorotov

Intraoperative IABP and levosimendan use in cardiас surgery

V. V. Lomivorotov, V. A. Boboshko, A. V. Boboshko, A. M. Cherniavskiy, D. A. Nikolaev, I. A. Kornilov, A. N. Shilova, V. N. Lomivorotov

Department of Anesthesiology and Perioperative Medicine

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

In this study we performed a comparative analysis of using intraoperative IABP and levosimendan in high risk cardiac patients (LVEF<35%) operated under CPB. In 10 patients, intra-aortic balloon pump was started immediately after induction of anesthesia; another 10 had a levosimendan infusion starting after induction of anesthesia with an initial bolus of 12 mg/kg^-1 for 10 min, followed by 0.1 mg/kg^-1 min^-1 for 24 h. Hemodynamics, troponin I levels, postoperative complications were analyzed. It was shown that the use of intraoperative IABP and levosimendan are effective ways of circulatory support. In addition, the use of levosimendan reduces the length of intensive care unit stay and hospitalization.

Original language	English (US)
Pages (from-to)	75-81
Number of pages	7
Journal	Kardiologiya i Serdechno-Sosudistaya Khirurgiya
Volume	6
Issue number	2
State	Published - 2013

All Science Journal Classification (ASJC) codes

Surgery
Cardiology and Cardiovascular Medicine

Cite this

@article{9ad7bf2b52d04780b3991e4f6eb07c31,

title = "Intraoperative IABP and levosimendan use in cardiас surgery",

abstract = "In this study we performed a comparative analysis of using intraoperative IABP and levosimendan in high risk cardiac patients (LVEF<35%) operated under CPB. In 10 patients, intra-aortic balloon pump was started immediately after induction of anesthesia; another 10 had a levosimendan infusion starting after induction of anesthesia with an initial bolus of 12 mg/kg-1 for 10 min, followed by 0.1 mg/kg-1 min-1 for 24 h. Hemodynamics, troponin I levels, postoperative complications were analyzed. It was shown that the use of intraoperative IABP and levosimendan are effective ways of circulatory support. In addition, the use of levosimendan reduces the length of intensive care unit stay and hospitalization.",

author = "Lomivorotov, {V. V.} and Boboshko, {V. A.} and Boboshko, {A. V.} and Cherniavskiy, {A. M.} and Nikolaev, {D. A.} and Kornilov, {I. A.} and Shilova, {A. N.} and Lomivorotov, {V. N.}",

year = "2013",

language = "English (US)",

volume = "6",

pages = "75--81",

journal = "Kardiologiya i Serdechno-Sosudistaya Khirurgiya",

issn = "1996-6385",

publisher = "Media Sphera Publishing Group",

number = "2",

}

TY - JOUR

T1 - Intraoperative IABP and levosimendan use in cardiас surgery

AU - Lomivorotov, V. V.

AU - Boboshko, V. A.

AU - Boboshko, A. V.

AU - Cherniavskiy, A. M.

AU - Nikolaev, D. A.

AU - Kornilov, I. A.

AU - Shilova, A. N.

AU - Lomivorotov, V. N.

PY - 2013

Y1 - 2013

N2 - In this study we performed a comparative analysis of using intraoperative IABP and levosimendan in high risk cardiac patients (LVEF<35%) operated under CPB. In 10 patients, intra-aortic balloon pump was started immediately after induction of anesthesia; another 10 had a levosimendan infusion starting after induction of anesthesia with an initial bolus of 12 mg/kg-1 for 10 min, followed by 0.1 mg/kg-1 min-1 for 24 h. Hemodynamics, troponin I levels, postoperative complications were analyzed. It was shown that the use of intraoperative IABP and levosimendan are effective ways of circulatory support. In addition, the use of levosimendan reduces the length of intensive care unit stay and hospitalization.

AB - In this study we performed a comparative analysis of using intraoperative IABP and levosimendan in high risk cardiac patients (LVEF<35%) operated under CPB. In 10 patients, intra-aortic balloon pump was started immediately after induction of anesthesia; another 10 had a levosimendan infusion starting after induction of anesthesia with an initial bolus of 12 mg/kg-1 for 10 min, followed by 0.1 mg/kg-1 min-1 for 24 h. Hemodynamics, troponin I levels, postoperative complications were analyzed. It was shown that the use of intraoperative IABP and levosimendan are effective ways of circulatory support. In addition, the use of levosimendan reduces the length of intensive care unit stay and hospitalization.

UR - http://www.scopus.com/inward/record.url?scp=85010848995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010848995&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85010848995

SN - 1996-6385

VL - 6

SP - 75

EP - 81

JO - Kardiologiya i Serdechno-Sosudistaya Khirurgiya

JF - Kardiologiya i Serdechno-Sosudistaya Khirurgiya

IS - 2

ER -

Intraoperative IABP and levosimendan use in cardiас surgery

Abstract

All Science Journal Classification (ASJC) codes

Other files and links

Fingerprint

Cite this